MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Inhibition of mitochondrial complexes induces unique transcriptomic and epigenetic profiles: implications to neurodegeneration induced movement disorders

    R. Sathyanarayanan, S. Bharath (Bangalore, India)

    Objective: To compare the neurotoxicological hallmarks induced by inhibitors of mitochondrial complex I (CI- 1- methyl-4- phenylpyridinium; MPP+), complex II (CII- 3- nitropropionic acid; 3-…
  • 2019 International Congress

    Population Exposure-Response Models of Apomorphine Sublingual Film in Healthy Subjects and Patients With Parkinson’s Disease and “OFF” Episodes

    F. Agbo, Y. Chiu, S. Chapel, G. Galluppi, D. Blum, B. Navia (Fort Lee, NJ, USA)

    Objective: Exposure-response models were developed to characterize the relationship between apomorphine exposure and (1) efficacy using Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease…
  • 2019 International Congress

    A possible case of prodromal DLB with prominent hallucinations, autonomic dysfunction, and REM behavior disorder but absence of cognitive impairment

    K. Amodeo (Rochester, NY, USA)

    Objective: Dementia with Lewy bodies (DLB) is the second most common cause of neurodegenerative dementia, after Alzheimer’s disease (AD). While mild cognitive impairment (MCI) is…
  • 2019 International Congress

    Neuroprotective effect of Yerba mate (Ilex paraguariensis) in a Drosophila model of Parkinson ’s disease

    P. Ballestero, A. Bernardi, H. Hauche Pedernera, O. Gershanik, N. Muraro, J. Ferrario (Capital Federal, Argentina)

    Objective: To test the neuroprotective capacity of Yerba Mate (YM) in an in vivo model of Parkinson's disease. Background: Parkinson's disease (PD) is caused by the…
  • 2019 International Congress

    A flowchart algorithm for the neurologist to discuss and attend sexual issues in Parkinson’s disease

    G. Bronner, S. Hassin-Baer, AD. Korczyn, T. Gurevich (Ramat-Gan, Israel)

    Objective: To propose guidelines for neurologists to discuss sexual issues and offer education and practical solutions. Background: Sexual dysfunction (SD) is a common nonmotor symptom…
  • 2019 International Congress

    The role of Parkinson’s disease-associated RHOT1/Miro1 variants in mitochondrial dysfunction and impaired cellular quality control

    A. Chemla, C. Berenguer-Escuder, F. Massart, P. Seibler, C. Klein, D. Grossmann, A. Grünewald, R. Krüger (Belvaux, Luxembourg)

    Objective: In the present study we intent to investigate the effect of mutant Miro1 proteins on mitochondrial function and cellular quality control mechanisms in iPSC-derived…
  • 2019 International Congress

    Cerebellar transcranial magnetic stimulation with neuronavigation for postural instability in PSP

    M. George, W. Devries, M. Dale (Charleston, SC, USA)

    Objective: We created a TMS protocol for paired-pulse cerebellar-M1 stimulation and repetitive cerebellar stimulation to augment cerebellar-brain inhibition and reduce postural instability in progressive supranuclear…
  • 2019 International Congress

    Synaptic function in Parkinson’s disease associated with GBA mutations

    T. Eid, R. Bandopadhyay, T. Lashley, J. Hardy, J. Holton, T. Warner, P. Francis (London, United Kingdom)

    Objective: To investigate the pathological substrate of impaired cognition in Parkinson’s disease (PD) associated with glucocerebrosidase (GBA) mutation. Background: Mutations in glucocerebrosidase gene (GBA), originally…
  • 2019 International Congress

    Clinical patterns of gait freezing in Parkinson’s disease and their response to interventions: an observer-blinded study

    O. Gavriliuc, S. Paschen, A. Andrusca, C. Schlenstedt, G. Deuschl (Chisinau, Republic of Moldova)

    Objective: To evaluate the occurrence and severity of FOG in provoking situations during a standard video-recorded walking task. To use this method to compare the effects…
  • 2019 International Congress

    The effect of coexistent neurodegenerative disorders on the clinical features of idiopathic normal pressure hydrocephalus

    A. Hattori, T. Tsunemi, N. Hattori (Bunkyo-Ku, Japan)

    Objective: To determine the prevalence of neurodegenerative disorders in idiopathic normal pressure hydrocephalus (iNPH) and their effects on the clinical features of iNPH. Background: To…
  • « Previous Page
  • 1
  • …
  • 144
  • 145
  • 146
  • 147
  • 148
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley